TransCode Therapeutics, Inc. (NASDAQ:RNAZ) Sees Large Increase in Short Interest

TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Free Report) was the target of a significant increase in short interest in December. As of December 15th, there was short interest totalling 52,400 shares, an increase of 184.8% from the November 30th total of 18,400 shares. Approximately 7.5% of the company’s stock are sold short. Based on an […]

Leave a Reply

Your email address will not be published.

Previous post Analysts Set IDEXX Laboratories, Inc. (NASDAQ:IDXX) Price Target at $539.63
Next post Saudi Arabia November 2024: Hyundai Elantra takes charge